Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment
Clinical trial NCT04587622 · COMPLETED
Trial details
- NCT number
- NCT04587622
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2022-09-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.